Isodol (Nimesulide)

Nimesulide works by selectively inhibiting the cyclo‑oxygenase‑2 (COX‑2) enzyme, which is responsible for converting arachidonic acid into prostaglandins that cause inflammation, pain, and fever. By blocking COX‑2, the drug lowers prostaglandin levels, thereby reducing the inflammatory response and providing analgesic effects.

The specific dose of Isodol is determined by the prescribing healthcare professional based on the patient’s condition, age, weight, and overall health status. Dosage instructions are provided on the prescription label and should be followed exactly as directed by the prescriber.

Safety data for nimesulide during pregnancy and lactation are limited, and the drug is generally not recommended for use in pregnant or breastfeeding women unless the potential benefit outweighs the risk. Physicians should evaluate each case individually and consider alternative therapies when possible.

To order Isodol, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide and will request verification of trade or institutional credentials. The sales team then provides pricing, availability, shipping details and any necessary import documentation.

Isodol (nimesulide) is a selective COX‑2 inhibitor, which may offer a lower risk of gastrointestinal irritation compared with non‑selective NSAIDs such as ibuprofen or diclofenac. However, it carries its own safety considerations, including potential liver toxicity, and should be chosen based on the patient’s overall risk profile and therapeutic needs.

Isodol tablets should be stored at room temperature below 25 °C, kept in the original packaging to protect from moisture and direct sunlight. Ensure the container is tightly closed and out of reach of children. Do not use the product after the expiry date printed on the label.

Isodol is taken orally, usually with a full glass of water. It can be taken with or without food, but patients who experience stomach upset may benefit from taking the tablet with meals. Swallow the tablet whole; do not crush, chew, or split it unless instructed by a healthcare professional.

The most serious risks linked to Isodol include severe liver injury (hepatotoxicity), life‑threatening allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome, and rare cardiovascular events like myocardial infarction or stroke. Patients should be monitored for signs of liver dysfunction, rash, or chest pain, and the drug should be discontinued immediately if serious adverse events occur.

Isodol should be avoided in individuals with known hypersensitivity to nimesulide or other NSAIDs, patients with active peptic ulcer disease, severe liver impairment, or uncontrolled heart failure. It is also contraindicated in patients taking certain anticoagulants or other COX‑2 inhibitors without close medical supervision.